BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31502471)

  • 1. Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening.
    Steponaviciene L; Vincerzevskiene I; Briediene R; Urbonas V; Vanseviciute-Petkeviciene R; Smailyte G
    Cancer Control; 2019; 26(1):1073274819874122. PubMed ID: 31502471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
    Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
    Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
    Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
    Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia.
    Heidinger O; Batzler WU; Krieg V; Weigel S; Biesheuvel C; Heindel W; Hense HW
    Dtsch Arztebl Int; 2012 Nov; 109(46):781-7. PubMed ID: 23264826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: Results of the Trento DBT pilot evaluation.
    Bernardi D; Gentilini MA; De Nisi M; Pellegrini M; Fantò C; Valentini M; Sabatino V; Luparia A; Houssami N
    Breast; 2020 Apr; 50():135-140. PubMed ID: 31607526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
    Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple way to measure the burden of interval cancers in breast cancer screening.
    Andersen SB; Törnberg S; Lynge E; Von Euler-Chelpin M; Njor SH
    BMC Cancer; 2014 Oct; 14():782. PubMed ID: 25344115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial.
    Harada-Shoji N; Suzuki A; Ishida T; Zheng YF; Narikawa-Shiono Y; Sato-Tadano A; Ohta R; Ohuchi N
    JAMA Netw Open; 2021 Aug; 4(8):e2121505. PubMed ID: 34406400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial.
    Skaane P; Sebuødegård S; Bandos AI; Gur D; Østerås BH; Gullien R; Hofvind S
    Breast Cancer Res Treat; 2018 Jun; 169(3):489-496. PubMed ID: 29429017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
    Chiarelli AM; Blackmore KM; Muradali D; Done SJ; Majpruz V; Weerasinghe A; Mirea L; Eisen A; Rabeneck L; Warner E
    J Natl Cancer Inst; 2020 Feb; 112(2):136-144. PubMed ID: 31233143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
    Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
    Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interval cancer rates in the Irish national breast screening programme.
    O'Brien KM; Dwane F; Kelleher T; Sharp L; Comber H
    J Med Screen; 2015 Sep; 22(3):136-43. PubMed ID: 25917389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection.
    Lehman CD; Wellman RD; Buist DS; Kerlikowske K; Tosteson AN; Miglioretti DL;
    JAMA Intern Med; 2015 Nov; 175(11):1828-37. PubMed ID: 26414882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and tumour characteristics of bilateral and unilateral interval breast cancers at screening mammography.
    van Bommel RMG; Voogd AC; Nederend J; Setz-Pels W; Louwman MWJ; Strobbe LJ; Venderink D; Tjan-Heijnen VCG; Duijm LEM
    Breast; 2018 Apr; 38():101-106. PubMed ID: 29306176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening.
    Sankatsing VDV; Fracheboud J; de Munck L; Broeders MJM; van Ravesteyn NT; Heijnsdijk EAM; Verbeek ALM; Otten JDM; Pijnappel RM; Siesling S; de Koning HJ;
    BMC Cancer; 2018 Mar; 18(1):256. PubMed ID: 29506487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early evaluation of an organised mammography screening program in Greece 2004-2009.
    Simou E; Tsimitselis D; Tsopanlioti M; Anastasakis I; Papatheodorou D; Kourlaba G; Gerasimos P; Maniadakis N
    Cancer Epidemiol; 2011 Aug; 35(4):375-80. PubMed ID: 21474412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.